⌘K

Login Start Free

Home/Filings/4/0001048477-24-000044

4//SEC Filing

Mueller Brian 4

Accession 0001048477-24-000044

CIK 0001048477other

View on SEC.gov Company Profile

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 8:48 PM ET

Size

8.3 KB

Accession

0001048477-24-000044

Insider Transaction Report

Form 4

Period: 2024-03-15

BIOMARIN PHARMACEUTICAL INCBMRN

VP, Corporate Controller

Transactions

Award
Common Stock
2024-03-15+11,400→ 92,648 total
Tax Payment
Common Stock
2024-03-15$83.87/sh−20,789$1,743,573→ 71,859 total
Award
Stock Option (Right to Buy Common Stock)
2024-03-15+25,540→ 25,540 total
Exercise: $83.87From: 2025-03-15Exp: 2034-03-14→ Common Stock (25,540 underlying)

Footnotes (2)

[F1]Restricted stock units granted March 15, 2024. Price not applicable.
[F2]Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.

Documents

1 file

4
wk-form4_1710895692.xmlPrimary
FORM 4

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1

filerCIK 0001514980

Filing Metadata

Form type: 4
Filed: Mar 18, 8:00 PM ET
Accepted: Mar 19, 8:48 PM ET
Size: 8.3 KB

View on SEC.gov